IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial record 1 of 2 for:
"Gliosis"
Observational Study - ILM Peeling
This study has been completed.
Sponsor:
University Hospital Tuebingen
Information provided by (Responsible Party):
M. Dominik Fischer, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01083056
First received: March 8, 2010
Last updated: July 30, 2014
Last verified: July 2014
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.
| Condition |
|---|
| Epimacular Gliosis Macular Hole |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling |
Further study details as provided by M. Dominik Fischer, University Hospital Tuebingen:
Primary Outcome Measures:
- BCVA [ Time Frame: 6 months after ILM peeling ]
| Enrollment: | 10 |
| Study Start Date: | March 2010 |
| Study Completion Date: | July 2014 |
| Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Epimacular Gliosis Without Macular Hole |
| Epimacular Gliosis With Macular Hole |
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Inpatients at the University Eye Hospital Tuebingen
Criteria
Inclusion Criteria:
- Clinical diagnosis of Epimacular Gliosis
- Must be scheduled for ILM-peeling independently of study
- Must be older then 18 years of age
Exclusion Criteria:
- Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
- Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01083056
Please refer to this study by its ClinicalTrials.gov identifier: NCT01083056
Locations
| Germany | |
| Centre for Ophthalmology, University Hospital Tuebingen | |
| Tuebingen, BW, Germany, 72076 | |
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
| Principal Investigator: | Florian Gekeler, MD | Centre for Ophthalmology, University Hospital Tuebingen |
More Information
| Responsible Party: | M. Dominik Fischer, PD Dr. med. M. Dominik Fischer, University Hospital Tuebingen |
| ClinicalTrials.gov Identifier: | NCT01083056 History of Changes |
| Other Study ID Numbers: |
ILM Peeling |
| Study First Received: | March 8, 2010 |
| Last Updated: | July 30, 2014 |
Keywords provided by M. Dominik Fischer, University Hospital Tuebingen:
|
retina gliosis macula membrane ILM |
Additional relevant MeSH terms:
|
Retinal Perforations Gliosis Retinal Diseases Eye Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on July 14, 2017